Ilaxten Oral Solution 2,5 mg/ml Oral solution
PDF Leaflet Revision Date: 04 June 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic treatment of allergic rhino-conjunctivitis and urticaria in children aged 6 to 11 years.
Dosage (summary)
10 mg (4 mL) once daily for children 6-11 years.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Preferable to avoid during pregnancy; excretion in breast milk not studied in humans.
Key Drug Interactions
- P-glycoprotein inhibitors
- Grapefruit juice
- Ketoconazole
- Erythromycin
Contraindications
- Hypersensitivity to bilastine or excipients
Common side effects
- Headache
- Allergic conjunctivitis
- Abdominal pain
- Somnolence
Counselling Points
- Take 1 hour before or 2 hours after food/fruit juice.
- Monitor for allergic reactions.
Serious warnings
- Avoid in children under 2 years
- Coadministration with P-glycoprotein inhibitors in renal impairment may increase plasma levels.
Important Disclaimer
The Ilaxten Oral Solution 2,5 mg/ml Oral solution professional information leaflet below is the property of Lebasi Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
